MAXIM INTEGRATED PRODUCTS INC
Categories of dependency expected for this filer that were actually found stated in Risk Factors / MD&A.
- Filing
- 0000743316-21-000025 (10-K)
- Period
- 2020-06-28 to 2021-06-26
- XBRL tag
- us-gaap:Revenues
- Context
- i8d7ead8272144a9db1128601a833f846_D20200628-20210626
- Mapping
- seed · confidence 1.00
Extracted from Risk Factors / MD&A, checked verbatim against the source text before being stored.
“uncertainty relating to the pending ADI Merger may cause current and prospective customers to consider alternatives, and potentially change suppliers”
“The ongoing novel coronavirus ("COVID-19") pandemic and the mitigation efforts by governments to attempt to control its spread are impacting and will likely continue to impact our operations, customers, and suppliers for an indefinite period of time.”
“the required regulatory approvals from governmental entities (U.S. and non-U.S.) may delay the completion of the ADI Merger or result in the imposition of conditions”
“potential adverse effects on our ability to attract, recruit, retain, and motivate current and prospective employees who may be uncertain about their future roles following the ADI Merger”
“the significant diversion of internal resources and key employees’ and management’s attention due to the pending ADI Merger”
“legal proceedings that may arise challenging the ADI Merger and the related transactions contemplated by the ADI Merger Agreement may require us to incur significant legal fees and expenses”
“the restrictions imposed on our business and operations under the ADI Merger Agreement may prevent us from pursuing opportunities without Analog Devices’ approval or taking other actions that we might have undertaken in the absence of the proposed ADI Merger, such as dividend payments, stock repurchases, and restructurings”
“we could be required to pay a termination fee of up to $725 million to Analog Devices under circumstances as described in the ADI Merger Agreement”